X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-6-2022-1649740823.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-17-2021-1637135168.pdf
https://www.juvisepharmaceuticals.com/wp-content/uploads/2020/04/Press-Release-Dartmouth-20122019-Eng-Juvis%C3%A9-Final.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212434
https://www.statnews.com/2020/06/04/oxford-astrazeneca-covid-19-deal-reinforces-vaccine-sovereignty/
https://www.statnews.com/2020/06/03/recapping-asco-2020-talking-cancer-therapy-combinations-and-looking-to-the-future/
https://www.astrazeneca.com/media-centre/press-releases/2020/lynparza-granted-orphan-drug-designation-in-japan-for-brca-mutated-metastatic-pancreatic-cancer.html
https://www.fiercepharma.com/marketing/ash-follow-up-survey-finds-physician-enthusiasm-around-car-t-off-shelf-therapies-and-btk
https://www.fiercepharma.com/marketing/ash-follow-up-survey-finds-physician-enthusiasm-around-car-t-off-shelf-therapies-and-btk
https://www.fiercepharma.com/marketing/ash-follow-up-survey-finds-physician-enthusiasm-around-car-t-off-shelf-therapies-and-btk
http://www.pharmafile.com/news/536087/astrazeneca-sells-amrimidx-and-casodex-european-rights-juvis-pharmaceuticals
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-26-2019-1561616031.pdf
https://www.fiercepharma.com/pharma/ada-j-j-s-struggling-invokana-slashes-heart-kidney-risks-latest-trial-win
https://www.fiercebiotech.com/biotech/inovio-shares-fall-as-astrazeneca-pares-down-partnership
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-14-2018-1542217134.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206037
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-25-2018-1524633895.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2018-1519803579.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-17-2018-1516166737.pdf
https://www.prnewswire.com/news-releases/ani-pharmaceuticals-acquires-four-ndas-from-astrazeneca-for-465-million-300576084.html
http://www.fiercepharma.com/pharma/az-oldie-faslodex-nets-another-breast-cancer-approval
http://www.pmlive.com/pharma_news/lilly_adds_to_data_backing_breast_cancer_candidate_abemaciclib_1194792
http://www.fiercepharma.com/marketing/valeant-slaps-3-500-sticker-third-to-market-psoriasis-launch-siliq
http://www.fiercepharma.com/pharma/big-pharma-faces-26-5b-patent-loss-threats-year-analyst-says
http://www.prnewswire.com/news-releases/heptares-to-receive-us12-million-milestone-payment-from-astrazeneca-618308413.html
http://www.reuters.com/article/us-astrazeneca-millendo-hot-flashes-idUSKBN1751RA
http://www.pharmatimes.com/news/nice_backs_use_of_drugs_for_breast_cancer_prevention_1189858
http://www.nasdaq.com/article/astrazeneca-reports-subgroup-analysis-from-falcon-trial--quick-facts-20161208-00451
http://www.pharmatimes.com/news/nice_backs_anastrozole_for_breast_cancer_prevention_1179364
http://www.pharmatimes.com/news/az_ups_stake_in_moderna_1095937
http://www.biospace.com/News/astrazeneca-plcs-fulvestrant-meets-goals-in-phase/421075/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
http://www.fiercepharma.com/pharma/astrazeneca-s-3b-push-for-tagrisso-gets-leg-up-from-clovis-setback
http://www.fiercepharma.com/pharma/merck-s-dpp-4-newcomer-marizev-trails-januvia-safety-report
http://www.fiercepharma.com/pharma/will-new-drug-spending-figures-increase-pressure-on-pharma
http://www.fiercepharmamarketing.com/story/vexing-ibs-d-spokescharacter-irritabelle-headlines-allergans-viberzi-ad-pus/2016-04-11
http://www.fiercebiotech.com/story/az-and-ventirx-team-pdl1-oncology-vax-trial-ovarian-cancer/2016-04-07
http://www.fiercepharmamarketing.com/story/lillys-new-psoriasis-med-taltz-sets-head-head-novartis-cosentyx/2016-03-23
http://www.statnews.com/pharmalot/2016/03/07/novartis-gleevec-cancer/
http://www.fiercepharmaasia.com/story/hk-based-chi-med-100m-ipo-set-march-14-interest-china-biopharma-booms/2016-03-06
http://www.fiercepharmamanufacturing.com/story/peregrines-avid-bioservices-unit-wraps-california-biologics-expansion/2016-03-07
http://www.fiercepharmamarketing.com/story/pharmas-dtc-ad-spending-soars-past-5-billion-2015/2016-03-07
http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30
http://www.prnewswire.com/news-releases/moderate-to-severe-pain-novel-abuse-deterrent-formulation-technologies-and-emergence-of-novel-mechanism-in-the-management-of-pain-300030890.html
http://www.alternet.org/personal-health/8-invented-diseases-big-pharma-banking
Market Place
Share 
